Bright Minds Biosciences (“BMB”) Proprietary 5-HT2C Agonists Show Significant Reduction in Binge Eating Post published:March 3, 2021 Post category:Press Release
Red Light Holland’s iMicro Digital Care App Launches Virtual Telecounseling with a Membership Program Led by Certified Therapist and Microdosing Expert Post published:March 3, 2021 Post category:Press Release
MINDCURE Announces Manufacturing of Synthetic Ibogaine to be Used in Company’s Clinical Research Post published:March 3, 2021 Post category:Press Release
Nova Mentis Launches Autism Microbiome Study in the United States Post published:March 3, 2021 Post category:Press Release
Awakn Announces Exclusive License Deal with the University of Exeter to Commercialise the ‘Ketamine in the Reduction of Alcoholic Relapse’ (KARE) Intervention Validated in a Phase II Clinical Trial Post published:March 2, 2021 Post category:Press Release
OPTIMI HEALTH and NUMINUS WELLNESS to Conduct Psychedelic Lab Research and Development Post published:March 2, 2021 Post category:Press Release
Red Light Holland Launches New Logo and Interactive Wisdom Truffle Companion Created by Internationally Renowned & Award-Winning Designer Karim Rashid Post published:March 2, 2021 Post category:Press Release
PsyBio Therapeutics Initiates Pilot Scale Development of Proprietary Biosynthetic Psilocybin with Global Contract Research, Development and Manufacturing Organization Post published:March 2, 2021 Post category:Press Release
COMPASS Pathways plc to announce fourth quarter and full year 2020 financial results on 9 March 2021 Post published:March 2, 2021 Post category:Press Release
PharmaTher Expands to Neuromuscular Diseases with Exclusive License Agreement for Ketamine in the Treatment of Lou Gehrig’s Disease Post published:March 2, 2021 Post category:Press Release